Identification of in vivo liver metabolites of Δ1 ‐tetrahydrocannabinol, cannabidiol, and cannabinol produced by the guinea‐pig
Identification of in vivo liver metabolites of Δ1 ‐tetrahydrocannabinol, cannabidiol, and cannabinol produced by the guinea‐pig
复制标题
豚鼠产生的 Δ1-四氢大麻酚、大麻二酚和大麻酚的体内肝脏代谢物的鉴定
DOI:
10.1111/j.2042-7158.1980.tb12910.x
复制
发表时间:
1980
影响因子:
3.3
通讯作者:
W. D. Paton
中科院分区:
文献类型:
--
作者:
D. Harvey;B. Martin;W. D. Paton
The metabolites of Δ1 ‐trahydrocannabinol (Δ1 ‐THC), cannabidiol (CBD), and cannabinol (CBN) produced in vivo by the guinea‐pig have been studied by combined gas‐liquid chromatography‐mass spectrometry. 45 metabolites of Δ1 ‐THC were identified of which 12 have not been reported before. Several other metabolites were detected but not identified. The major metabolic routes involved allylic and aliphatic hydroxylations, oxidations to ketones and acids, oxidative degradation of the side‐chain presumably by the β‐oxidation pathway, and formation of glucuronide conjugates. Di‐ and tri‐substituted metabolites were abundant. The metabolism differed considerably from that observed in mouse and rat in that 1″‐ and 6β‐hydroxylation and oxidative degradation of the side‐chain were major metabolic pathways. 1″‐Hydroxy‐Δ1 ‐THC was found as a pair of diasteroisomers. Similar metabolic pathways were observed with CBD; twenty metabolites were identified of which two were new. Only 6 metabolites of CBN were identified. These were mainly mono‐substituted in the same positions as were observed with Δ1 ‐THC and CBD.